IncellDx, GeneCell Ink Pact to Offer HPV Test in India | GenomeWeb

NEW YORK (GenomeWeb News) – IncellDx today said it has reached a deal to offer its molecular diagnostic test for human papillomavirus in India.

Under the terms of the deal, New Delhi-based GeneCell Diagnostics will offer IncellDx's test for detecting oncogenic HPV E6, E7 mRNA through its laboratory partner CureHealth Diagnostics, which will be the first reference lab in India to offer the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.